Hypogonadism in the HIV-infected man

Area of Science:

• Endocrinology
• Infectious Diseases
• Men's Health

Background:

• Androgen deficiency, or hypogonadism, is common in men with human immunodeficiency virus (HIV).
• Antiretroviral therapies have decreased the incidence of hypogonadism in HIV-infected men.
• The causes of testosterone deficiency in HIV are complex and multifactorial.

Purpose of the Study:

• To explore the mechanisms behind testosterone deficiency in HIV-infected men.
• To outline diagnostic criteria for hypogonadism in this population.
• To provide recommendations for testosterone replacement therapy.

Main Methods:

• Review of proposed mechanisms for hypogonadism in HIV.
• Emphasis on clinical symptoms and testosterone measurement for diagnosis.
• Discussion of confounding factors in interpreting biochemical tests.

Main Results:

• Potential causes include medications, fat redistribution, and poor health status, leading to hypogonadotropic hypogonadism.
• Diagnosis requires clinical symptoms alongside testosterone level assessment.
• Interpreting testosterone levels can be challenging due to confounding factors in HIV patients.

Conclusions:

• Hypogonadism is a significant concern in men with HIV.
• Accurate diagnosis relies on clinical presentation and objective testing.
• Testosterone therapy should be considered for symptomatic HIV-infected men with confirmed hypogonadism, especially those with lean mass loss.